Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Non-cash Items (2019 - 2025)

Neuroone Medical Technologies posted quarterly Non-cash Items of $999882.0 for Q3 2025, up 4307.68% year-on-year from $22685.0 in Q3 2024, and up 4307.68% on a QoQ basis from $22685.0 in Q3 2024.

Neuroone Medical Technologies (NMTC) has 5 years of Non-cash Items data on file, last reported at $999882.0 in Q3 2025.

  • For the quarter ending Q3 2025, Non-cash Items rose 4307.68% year-over-year to $999882.0; the trailing twelve-month figure through Sep 2025 stood at $999882.0 (up 4307.68% YoY), and the FY2025 full-year result was $999882.0, up 4307.68% from the prior year.
  • Non-cash Items for Q3 2025 stood at $999882.0, up from $22685.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $999882.0 in Q3 2025 and bottomed at $20064.0 in Q3 2023.
  • The 4-year median for Non-cash Items is $55990.0 (2022), against an average of $282981.5.
  • The widest annual swing landed in 2023, when Non-cash Items tumbled 77.53%; it then surged 4307.68% in 2025.
  • A 4-year view of Non-cash Items shows it stood at $89295.0 in 2022, then sank by 77.53% to $20064.0 in 2023, then grew by 13.06% to $22685.0 in 2024, then soared by 4307.68% to $999882.0 in 2025.
  • The last three Non-cash Items figures came in at $999882.0 (Q3 2025), $22685.0 (Q3 2024), and $20064.0 (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Neuroone Medical Technologies 31.39 Mn 28.59 Mn 1.29 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 999,882.00
Sep 30, 2025 999,882.00
Sep 30, 2024 22,685.00
Sep 30, 2024 22,685.00
Sep 30, 2023 20,064.00
Sep 30, 2023 20,064.00
Sep 30, 2022 89,295.00
Sep 30, 2022 89,295.00
Mar 31, 2019 93,555.00
Mar 31, 2019 93,555.00